 High-dose intravenous IgG treatment renal function open trial high intravenous IgG IVIG treatment nephrotic patients glomerulonephritis first patients studied transient rise plasma creatinine increase symptoms urinary deposit unchanged patients pre-existing renal impairment nephrotic syndrome transient reversible rise plasma creatinine IVIG observations high-dose IVIG infusion short-lived disturbances renal function patients kidney diseases